spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

CrystecPharma win CPhI Excellence in Pharma Award for Contract Services and Outsourcing

Crystec are delighted to have been awarded the CPhI Excellence in Pharma Award for Contract Services and Outsourcing

The award was presented for Crystec’s modified supercritical anti-solvent (mSAS) technology for accelerated product development, and chosen from shortlisted companies including 3M, Alcami, Catalent Pharma Services and Merck.

The winners of the CPhI Awards were announced on Tuesday 24th October during an awards gala in Frankfurt, Germany. Crystec’s CEO, Paul Thorning, said of the prestigious award: “It is our great pleasure to have been recognised for our work across the industry through our expertise in crystallisation and particle engineering. Our mSAS technology platform has the potential, not only to add value to product development programmes through improving the performance of medicines, but to streamline product development, reduce manufacturing costs and accelerate the route to market. We are very proud of our company and of the solutions that we provide for our clients, as well as our own development programmes. We are particularly honoured to have won this award in the company of such renowned organisations.”

For more information about Crystec’s mSAS technology, please contact Emily Bevis (emily.bevis@crystecpharma.com).

About CPhI
The International Convention on Pharmaceutical Ingredients and Intermediates (CPhI) hold several events each year aimed at bringing together people from across the pharmaceutical supply chain. CPhI Worldwide is the largest and most diverse gathering of pharmaceutical professionals in the world. With over 42,000 visiting professionals and more than 2500 exhibitors from 153 countries, there is no better platform to explore new business opportunities.

About CPhI Awards
Established in 2004, the CPhI Pharma Awards are among the most prestigious recognitions within the Pharmaceutical industry. The Awards celebrates thinkers and creators breaking new ground and strongly advocates companies committed to driving the industry forward.


About Crystec
CrystecPharma is a pharmaceutical crystal and particle engineering company, applying supercritical fluid technology to improve the performance of medicines. The company has a strong research and development base, in both the UK and China. Crystec supports pharmaceutical companies to optimise the development of their own products, typically through improving bioavailability, stability or changing routes of administration. The company also applies the strength of its technology to develop its own supergeneric products. Crystec is a young, dynamic company, with a passion for ensuring that strong science benefits human health. For more information, please visit www.crystecpharma.com.

Crystec Ltd.
Norcroft Building
Richmond Road
Bradford, United Kingdom
BD7 1DP

T: +44 1274 235592
E: info@crystecpharma.com
 
Print this page
Send to a friend
   
spacer
News and Press Releases

FlyPharma Conference Europe concludes its fourth successful year in Brussels, Belgium, 5-6 June 2018

The FlyPharma Conference Europe wrapped up for another year on 6 June, returning with an expanded roster of speakers who provided insight into all aspects of the pharmaceutical supply chain. The event was once again hosted at the Sheraton Brussels Airport Hotel and the Host Partner, Brussels Airport, as always provided speakers and insight into its own experiences working directly with a number of supply chain stakeholders.
More info >>


White Papers

Detecting Integrity Breaches in a range of Pharmaceutical Blister Package Types using Sepha VisionScan

Sepha Limited

Demonstrating the integrity of pharmaceutical blister packs is critically important, as any defects can affect the shelf life and efficacy of the contents. Compared to bulk packaging, blister packs offer improved product integrity, tamper evidence and reduce the likelihood of misuse. Packs can be composed of either a thermoformed polymer or cold formed aluminium tray, with a number of individual pockets to hold the product. After the tablets or capsules are placed in the pockets, the packs are heat sealed with a paper or foil laminate sheet. These various stages can be completed separately or integrated into a single form, fill and seal process. There is a risk of microbial containment or degradation of the contents if any defects are present in the packaging. Such defects can take the form of rips or pinholes in the tray, or lid materials, faulty seals and channel leaks between pockets.
More info >>

Industry Events

BioPharm America 2018

5-6 September 2018, Hynes Convention Center

BioPharm America™ is a unique partnering event that forms the nexus of discovery and realization. Startup companies, established biotech and entrepreneurs from academia attend in search of finance, pharma and development partners. The event format highlights innovation and promotes new business relationships by bringing dealmakers from the life science ecosystem together to engage and de-risk the enormous task of drug development.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement